Implicit Bioscience

Queensland, AUS
12 Total Employees
Year Founded: 2005

Similar Companies Hiring

Pharmaceutical • Healthtech • Biotech • Big Data • Artificial Intelligence
New York, NY
140 Employees
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
3 Offices
450 Employees
Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
38 Offices
121990 Employees
Implicit Bioscience is an unlisted public company based in Brisbane and Seattle. It was founded in 2005 by a number of biopharma veterans including Prof. Peter Andrews AO and Prof. Ian Frazer AC FRS; the company’s mission is to apply groundbreaking immunotherapy to treat serious and life-threatening diseases with few or no effective treatments. Implicit Bioscience holds worldwide rights to IC14 and is developing it in the new field of immunoneurology for a range of neurodegenerative and neurotraumatic disease indications. IC14 is a biologic monoclonal antibody drug that inactivates CD14 on immune cells and in circulation. CD14 is a master regulator of the immune response that is also a key organiser of responses by the brain’s most common immune cell to infection and injury. Hyper-activated CD14 results in damaging inflammation that kills healthy brain and other cells in diseases such as MND/ALS.

Implicit Bioscience Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
Queensland, AUS